N4 Pharma announces success in positive in vivo results from first Nuvec study for IBD dual-loaded with siRNA and mRNA
Nuvec is N4 Pharma’s proprietary gene delivery system being developed to safely and effectively transport RNA therapies for cancer and other diseases